Nykode Therapeutics AS (OTCMKTS:VACBF – Get Free Report) was the target of a large growth in short interest in the month of June. As of June 15th, there was short interest totaling 980 shares, a growth of ∞ from the May 31st total of 0 shares. Based on an average daily volume of 367 shares, the days-to-cover ratio is currently 2.7 days.
Nykode Therapeutics AS Price Performance
VACBF opened at $0.32 on Wednesday. Nykode Therapeutics AS has a 1 year low of $0.32 and a 1 year high of $0.36. The firm has a 50 day moving average price of $0.36 and a 200 day moving average price of $0.32.
About Nykode Therapeutics AS
Nykode Therapeutics AS (OTCMKTS:VACBF) is a clinical-stage biotechnology company based in Oslo, Norway, focused on the development of precisely targeted immunotherapies. The company’s proprietary platform is designed to deliver antigenic payloads directly to antigen-presenting cells, with the goal of eliciting potent and durable immune responses against both cancerous and infectious disease targets. By combining modular antigen design with novel delivery modalities, Nykode aims to drive next-generation vaccine and immunotherapy solutions.
The company’s clinical pipeline includes several lead candidates in oncology and infectious diseases.
Recommended Stories
- Five stocks we like better than Nykode Therapeutics AS
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Receive News & Ratings for Nykode Therapeutics AS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nykode Therapeutics AS and related companies with MarketBeat.com's FREE daily email newsletter.
